Breaking NewsLaw.com and associated brands will be offline for scheduled maintenance Friday Feb. 26 9 PM US EST to Saturday Feb. 27 6 AM EST. We apologize for the inconvenience.

 
X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Ten months after a jury in Angleton returned a $253.4 million verdict in the nation’s first Vioxx trial, 23rd District Judge Ben Hardin signed a final judgment awarding the plaintiffs $26.1 million in damages, plus $1.25 million in pre-judgment interest. In a final judgment signed on June 23, Hardin ordered defendant pharmaceutical company Merck & Co. Inc. to pay the plaintiffs $24.45 million in actual damages but reduced the verdict’s $220 million in punitive damages to the statutory cap of $1.65 million. The jury in Carol A. Ernst, et al. v. Merck & Co. Inc. found negligence by Merck was a proximate cause in the death of Robert Ernst, a 59-year-old Wal-Mart employee who died in 2001. The jury also found that a marketing defect in Vioxx and a design defect in the painkiller were producing causes in Ernst’s death. Ernst’s widow and his children sued Merck, based in New Jersey, in 2002. Also on June 23, Hardin denied Merck’s motion seeking a judgment notwithstanding the verdict. Plaintiffs’ lawyer W. Mark Lanier, of the Lanier Law Firm in Houston, says he is pleased with the judgment but will appeal it on the grounds that Texas’ statutory cap on punitive damages is unconstitutional. A member of Merck’s trial team, Jonathan Skidmore, a partner in Fulbright & Jaworski in Dallas, says, “We are anxious to get the appellate process started. We think the judgment properly applied the caps under Texas law. We get to go test the verdict now at the next level.”

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

 
 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.